Back
Ultra Clean Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
38
UCTT
Ultra Clean Holdings
Last Price:
$24.52
Seasonality Move:
6.53%
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
Sell
38
Ultra Clean Holdings (UCTT)
is a Sell
Is Ultra Clean Holdings a Buy, Sell or Hold?
-
The current Ultra Clean Holdings [UCTT] share price is $24.85. The Score for UCTT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
UCTT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UCTT Stock Price Chart
What is Ultra Clean Holdings's stock price today?
-
The Ultra Clean Holdings share price today is $24.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UCTT is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $290.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
UCTT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.41 | Sell |
| Relative Strength Index (14 RSI): | 38.25 | Sell |
| Chaikin Money Flow: | -134597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.12 - 33.7) | Sell |
| Bollinger Bands (100): | (29.61 - 39.63) | Sell |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.72 | Buy |
| Relative Strength Index (14 RSI): | 71.41 | Buy |
| Chaikin Money Flow: | -979016 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.44 - 263) | Buy |
| Bollinger Bands (100): | (240.32 - 271.8) | Buy |
UCTT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.87 | Sell |
| 20-day SMA: | 25.32 | Sell |
| 50-day SMA: | 32.57 | Sell |
| 200-day SMA: | 38.22 | Sell |
| 8-day EMA: | 24.84 | Buy |
| 20-day EMA: | 26.62 | Sell |
| 50-day EMA: | 30.61 | Sell |
| 200-day EMA: | 35.9 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 257.74 | Buy |
| 20-day SMA: | 249.75 | Buy |
| 50-day SMA: | 257.54 | Buy |
| 200-day SMA: | 251.5 | Buy |
| 8-day EMA: | 263.89 | Buy |
| 20-day EMA: | 256.08 | Buy |
| 50-day EMA: | 255.39 | Buy |
| 200-day EMA: | 243.44 | Buy |
Ultra Clean Holdings Earnings Growth & UCTT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.24 per share, an increase this year of $0.52 per share, and an increase next year of $1.09 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Ultra Clean Holdings Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||